Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,073,344
-$1,242,358 QoQ
Shares Held
1,131,028
-44.3% QoQ
Ownership
0.268%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Mar 31, 2026CallValue
$1,377,568
CallShares
1,451,600
PutValue
$621,310
PutShares
654,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $928,363,116 across 59 Drug Manufacturers - Specialty & Generic names. CGC ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
360,643 | $213,854,086 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,574,044 | $108,936,860 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
4,387,127 | $104,983,948 | |
| 4 | ALKS |
Alkermes plc.
|
2,241,584 | $79,262,409 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,493,446 | $77,196,223 | |
| 6 | ZTS |
Zoetis Inc.
|
501,011 | $59,224,510 | |
| 7 | VTRS |
Viatris Inc
|
3,993,155 | $53,947,523 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
474,750 | $22,859,212 |
All Filings in CGC
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,073,344 | 1,131,028 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,377,568 | 1,451,600 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $621,310 | 654,700 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,406,326 | 1,233,620 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $3,585,060 | 3,144,790 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $2,315,702 | 2,031,319 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,318,832 | 3,643,036 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,615,560 | 1,791,480 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,203,113 | 824,050 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $755,924 | 619,610 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,164,878 | 954,819 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $1,308,572 | 1,072,600 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $579,779 | 637,120 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $751,532 | 825,860 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $2,846,120 | 1,038,730 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $437,112 | 159,530 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $2,104,758 | 768,160 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $984,836 | 204,323 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $10,678,131 | 2,215,380 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $4,215,090 | 874,500 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $9,837,604 | 1,525,210 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $965,887 | 149,750 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $8,818,246 | 1,367,170 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $11,064,695 | 1,282,120 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $3,339 | 387 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $6,489,242 | 751,940 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $1,274,076 | 249,330 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $6,980 | 1,366 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $484,836 | 94,880 | Put | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||